@incollection{, 4037E46CA3A3BC8E3600BE5C31F2DC32 , author={{AliceBranton} and {SnehasisJana}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}185715 } @incollection{b0, , title={{Hepatocellular carcinoma: Epidemiology and risk factors}} , author={{ MCKew }} , journal={{J Hepatocell Carcinoma}} 1 , year={2014} } @incollection{b1, , title={{Liv.52 protects HepG2 cells from oxidative damage induced by tert-butyl hydroperoxide}} , author={{ SK MVidyashankar }} , journal={{Mol Cell Biochem}} 333 , year={2010} } @incollection{b2, , title={{Protective effect of aqueous extract of Perilla frutescens on tert-butyl hydroperoxideinduced oxidative hepatotoxicity in rats}} , author={{ MKKim } and { LeeH S } and { KimE JWon } and { NH } and { ChiY }} , journal={{Food Chem Toxicol}} 45 , year={2007} } @incollection{b3, , title={{Assessment of hepatocytes and liver slices as in vitro test systems to predict in vivo gene expression}} , author={{ BAJessen } and { JSMullins } and { ADe Peyster } and { GStevens }} , journal={{Toxicol Sci}} 75 , year={2003} } @incollection{b4, , title={{Bromobenzene detoxification in the human liverderived HepG2 cell line}} , author={{ SJDuthie } and { MelvinW T } and { BurkeM }} , journal={{Xenobiotica}} 24 , year={1994} } @incollection{b5, , title={{Drug metabolism by the human hepatoma cell, HepG2}} , author={{ SSassa } and { OSugita } and { RAGalbraith } and { AKappas }} , journal={{Biochem Biophys Res Commun}} 143 , year={1987} } @incollection{b6, , title={{Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach}} , author={{ SKLutgendorf } and { EMullen-Houser } and { DRussell } and { KDegeest } and { GJacobson }} , journal={{Brain Behav Immun}} 24 , year={2010} } @incollection{b7, , title={{Massage therapy is associated with enhancement of the immune system's cytotoxic capacity}} , author={{ GIronson } and { TField } and { FScafidi } and { MHashimoto } and { MKumar }} , journal={{Int J Neurosci}} 84 , year={1996} } @incollection{b8, , title={{A transcendental to changing metal powder characteristics}} , author={{ MKTrivedi } and { RTallapragada }} , journal={{Met Powder Rep}} 63 31 , year={2008} } @incollection{b9, , title={{Studies of the atomic and crystalline characteristics of ceramic oxide nano powders after bio field treatment}} , author={{ MKTrivedi } and { GNayak } and { SPatil } and { RMTallapragada } and { OLatiyal }} , journal={{Ind Eng Manage}} 4 161 , year={2015} } @incollection{b10, , title={{Effect of biofield energy treatment on physical and structural properties of calcium carbide and praseodymium oxide}} , author={{ MKTrivedi } and { GNayak } and { SPatil } and { RMTallapragada } and { OLatiyal }} , journal={{International Journal of Materials Science and Applications}} 4 , year={2015} } @incollection{b11, , title={{Morphological characterization, quality, yield and DNA fingerprinting of biofield energy treated alphonso mango (Mangifera indica L.)}} , author={{ MKTrivedi } and { ABranton } and { DTrivedi } and { GNayak } and { MondalS C }} , journal={{Journal of Food and Nutrition Sciences}} 3 , year={2015} } @book{b12, , title={{Evaluation of biochemical}} , author={{ MKTrivedi } and { ABranton } and { DTrivedi } and { GNayak } and { MondalS C }} , year={2015} } @incollection{b13, , title={{Phenotyping and 16S rDNA analysis after biofield treatment on Citrobacter braakii: A urinary pathogen}} , author={{ MKTrivedi } and { ABranton } and { DTrivedi } and { GNayak } and { SCharan }} , journal={{J Clin Med Genom}} 3 129 , year={2015} } @incollection{b14, , title={{Evaluation of biofield modality on viral load of Hepatitis B and C viruses}} , author={{ MKTrivedi } and { SPatil } and { HShettigar } and { MondalS C } and { JanaS }} , journal={{J Antivir Antiretrovir}} 7 , year={2015} } @incollection{b15, , title={{An impact of biofield treatment: Antimy cobacterial susceptibility potential using BACTEC 460 / MGIT-TB System}} , author={{ MKTrivedi } and { SPatil } and { HShettigar } and { MondalS C } and { JanaS }} , journal={{Mycobact Dis}} 5 189 , year={2015} } @incollection{b16, , title={{Phenotypic and biotypic characterization of Klebsiella oxytoca: An impact of biofield treatment}} , author={{ MKTrivedi } and { SPatil } and { HShettigar } and { KBairwa } and { JanaS }} , journal={{J Microb Biochem Technol}} 7 , year={2015} } @incollection{b17, , title={{Effect of biofield treatment on plant growth and adaptation}} , author={{ GNayak } and { NAltekar }} , journal={{J Environ Health Sci}} 1 , year={2015} } @incollection{b18, , title={{A Systematic study of the biofield energy healing treatment on physicochemical, thermal, structural, and behavioral properties of magnesium gluconate}} , author={{ MKTrivedi } and { ABranton } and { DTrivedi } and { GNayak } and { WDPlikerd }} , journal={{International Journal of Bioorganic Chemistry}} 2 , year={2017} } @incollection{b19, , title={{Improved metabolism of vitamin d3 in human osteoblasts cells after biofield energy healing treatment}} , author={{ VRParulkar } and { MKTrivedi } and { ABranton } and { DTrivedi } and { GNayak }} , journal={{American Journal of Laboratory Medicine}} 3 , year={2018} } @incollection{b20, , title={{The potential impact of biofield treatment on human brain tumor cells: A time-lapse video microscopy}} , author={{ MKTrivedi } and { SPatil } and { HShettigar } and { MondalS C } and { JanaS }} , journal={{J Integr Oncol}} 4 141 , year={2015} } @incollection{b21, , title={{In vitro evaluation of biofield treatment on cancer biomarkers involved in endometrial and prostate cancer cell lines}} , author={{ MKTrivedi } and { SPatil } and { HShettigar } and { MGangwar } and { JanaS }} , journal={{J Cancer Sci Ther}} 7 , year={2015} } @incollection{b22, , title={{The influence of energy of consciousness healing treatment on low bioavailable resveratrol in male Sprague Dawley rats}} , author={{ ABranton } and { SJana }} , journal={{International Journal of Clinical and Developmental Anatomy}} 3 , year={2017} } @incollection{b23, , title={{The use of novel and unique biofield energy healing treatment for the improvement of poorly bioavailable compound, berberine in male Sprague Dawley rats}} , author={{ ABranton } and { SJana }} , journal={{American Journal of Clinical and Experimental Medicine}} 5 , year={2017} } @incollection{b24, , title={{Effect of The biofield energy healing treatment on the pharmacokinetics of 25-hydroxyvitamin D3 [25(OH)D 3 ] in rats after a single oral dose of vitamin D3}} , author={{ ABranton } and { SJana }} , journal={{American Journal of Pharmacology and Phytotherapy}} 2 , year={2017} } @incollection{b25, , title={{The use of consciousness energy healing based herbomineral formulation for skin anti-aging strategies}} , author={{ VRParulkar } and { MKTrivedi } and { ABranton } and { DTrivedi } and { GNayak }} , journal={{Journal of Food and Nutrition Sciences}} 5 , year={2017} } @incollection{b26, , title={{Consciousness energy healing treatment based herbomineral formulation: A safe and effective approach for skin health}} , author={{ JSingh } and { MKTrivedi } and { ABranton } and { DTrivedi } and { GNayak }} , journal={{American Journal of Pharmacology and Phytotherapy}} 2 , year={2017} } @incollection{b27, , title={{Influence of biofield treated vitamin D3 on proliferation, differentiation, and maturation of bone -related parameters in MG -63 cell -line}} , author={{ DAnagnos } and { KTrivedi } and { ABranton } and { DTrivedi } and { GNayak }} , journal={{International Journal of Biomedical Engineering and Clinical Science}} 4 , year={2018} } @incollection{b28, , title={{The potential benefits of biofield energy treated vitamin D3 on bone mineralization in human bone osteosarcoma cells (MG-63)}} , author={{ LeeA CTrivedi } and { KBranton } and { ATrivedi } and { DNayak } and { G }} , journal={{International Journal of Nutrition and Food Sciences}} 7 , year={2018} } @incollection{b29, , title={{Biofield energy treated vitamin D3: Therapeutic implication on bone health using osteoblasts cells}} , author={{ MEStutheit } and { KTrivedi } and { ABranton } and { DTrivedi } and { GNayak }} , journal={{American Journal of Life Sciences}} 6 , year={2018} } @incollection{b30, , title={{Cytoprotective effect exerted by geraniin in HepG2 cells is through microRNA mediated regulation of BACH-1 and HO-1}} , author={{ HAayadi } and { SP KMittal } and { ADeshpande } and { MGore } and { GhaskadbiS }} , journal={{BMB Rep}} 50 , year={2017} } @incollection{b31, , title={{Cytoprotective effects of arbutin against tert-butyl hydroperoxid induced toxicity in Hep-G2 cell Line}} , author={{ NSeyfizadeh } and { SMahjoub } and { EZabihi } and { AMoghadamnia } and { MPouramir }} , journal={{World Appl Sci J}} 19 , year={2012} } @incollection{b32, , title={{Neutrophilactivating peptide-1/interleukin 8, a novel cytokine that activates neutrophils}} , author={{ MBaggiolini } and { AWalz } and { SLKunkel }} , journal={{J Clin Invest}} 84 , year={1989} } @incollection{b33, , title={{Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis}} , author={{ HWZimmermann } and { SSeidler } and { NGassler } and { JNattermann } and { TLuedde }} , journal={{PLoS One}} 6 6 e21381 , year={2011} } @incollection{b34, , title={{Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: Evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation}} , author={{ SVlahopoulos } and { IBoldogh } and { ACasola } and { ARBrasier }} , journal={{Blood}} 94 , year={1999} } @incollection{b35, , title={{Interleukin 8 response and oxidative stress in HepG2 cells treated with ethanol, acetaldehyde or lipopolysaccharide}} , author={{ LGómez-Quiroz } and { LBucio } and { VSouza } and { CEscobar } and { BFarfán }} , journal={{Hepatol Res}} 26 2 , year={2003} } @incollection{b36, , title={{Evaluation of abnormal liver-enzyme results in asymptomatic patients}} , author={{ DSPratt } and { MKaplan }} , journal={{N Engl J Med}} 342 , year={2000} } @incollection{b37, , title={{The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients}} , author={{ UMathiesen } and { LFranzen } and { AFryden } and { UFoberg } and { GBodemar }} , journal={{Scand J Gastroenterol}} 34 , year={1999} } @incollection{b38, , title={{Cholesterol, lipid rafts, and disease}} , author={{ KSimons } and { REhehalt }} , journal={{J Clin Invest}} 110 , year={2002} } @incollection{b39, , title={{Nutrition and nonalcoholic fatty liver disease: The significance of cholesterol}} , author={{ MEnjoji } and { KYasutake } and { MKohjima } and { MNakamuta }} ID 925807 , journal={{Int J Hepatol}} 6 , year={2012. 2012. 2012} } @incollection{b40, , title={{Review article: Albumin as a drug-biological effects of albumin unrelated to oncotic pressure}} , author={{ TEvans }} , journal={{Aliment Pharmacol Ther}} 5 , year={2002} } @incollection{b41, , title={{Administration of albumin to patients with sepsis syndrome: A possible beneficial role in plasma thiol repletion}} , author={{ GJQuinlan } and { MargarsonM PMumby } and { SEvans } and { TW } and { GutteridgeJ }} , journal={{Clin Sci}} 95 , year={1998} } @incollection{b42, , title={{Relevance of albumin in modern critical care medicine}} , author={{ JVincent }} , journal={{Best Pract Res Clin Anaesthesiol}} 23 , year={2009} } @incollection{b43, , title={{Clinical use of albumin in hepatology}} , author={{ MGarcovich } and { MAZocco } and { AGasbarrini }} , journal={{Blood Transfus}} 7 4 , year={2009} } @incollection{b44, , title={{Albumin in chronic liver disease: Structure, functions and therapeutic implications}} , author={{ RSpinella } and { RSawhney } and { RJalan }} , journal={{Hepatol Int}} 10 1 , year={2016} }